The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia is a Strong Predictor for Survival

被引：0
|
作者：
Yilmaz, Musa [1 ]
Kantarjian, Hagop [1 ]
Wang, Xuemei [2 ]
Loghavi, Sanam [3 ]
Khoury, Joseph [3 ]
Jorgensen, Jeffrey [3 ]
Ravandi, Farhad [1 ]
Short, Nicholas [1 ]
Cortes, Jorge [1 ]
Garcia-Manero, Guillermo [1 ]
Kadia, Tapan [1 ]
Sasaki, Koji [1 ]
Konopleva, Marina [1 ]
Takahashi, Koichi [1 ]
Wierda, William [1 ]
Khouri, Maria [1 ]
Jain, Nitin [1 ]
Verstovsek, Srdan [1 ]
Estrov, Zeev [1 ]
Bose, Prithviraj [1 ]
Pierce, Sherry [1 ]
Garris, Rebecca [1 ]
O'Brien, Susan [4 ]
Jabbour, Elias [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
minimal residual disease; ALL; survival; early; acute lymphoblastic leukemia;
D O I：
10.1016/j.clml.2019.07.040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ALL-280
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [31] Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Nerve
    Giebel, Sebastian
    Bruggemann, Monika
    Doubek, Michael
    Foa, Robin
    Hoelzer, Dieter
    Kim, Christopher
    Martinelli, Giovanni
    Parovichnikova, Elena
    Rambaldi, Alessandro
    Ribera, Josep-Maria
    Schoonen, Marieke
    Stieglmaier, Julia M.
    Zugmaier, Gerhard
    Bassan, Renato
    HEMATOLOGY, 2019, 24 (01) : 337 - 348
  • [32] Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings
    Menon, Hari
    Singh, Pawan Kumar
    Bagal, Bhausaheb
    Dolai, Tuphan
    Jain, Ankita
    Chaudhri, Antara
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (01) : 1 - 11
  • [33] Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings
    Hari Menon
    Pawan Kumar Singh
    Bhausaheb Bagal
    Tuphan Dolai
    Ankita Jain
    Antara Chaudhri
    Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 1 - 11
  • [34] The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia
    Verbeek, Martijn W. C.
    van der Velden, Vincent H. J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [35] CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease
    Mannelli, Francesco
    Gianfaldoni, Giacomo
    Intermesoli, Tamara
    Cattaneo, Chiara
    Borlenghi, Erika
    Cortelazzo, Sergio
    Cavattoni, Irene
    Pogliani, Enrico Maria
    Fumagalli, Monica
    Angelucci, Emanuele
    Romani, Claudio
    Ciceri, Fabio
    Corti, Consuelo
    Scattolin, Anna
    Cortelezzi, Agostino
    Mattei, Daniele
    Audisio, Ernesta
    Spinelli, Orietta
    Oldani, Elena
    Bosi, Alberto
    Rambaldi, Alessandro
    Bassan, Renato
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (04): : 568 - 571
  • [36] Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    Eckert, Cornelia
    Hrusak, Ondrej
    Buldini, Barbara
    Sartor, Mary
    Zugmaier, Gerhard
    Zeng, Yi
    Pilankar, Deepali
    Morris, Joan
    von Stackelberg, Arend
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [37] Development of Inotuzumab Ozogamicin and Blinatumomab for Frontline Treatment of Older Patients with Ph-Negative B-Cell Acute Lymphoblastic Leukemia
    Wieduwilt, Matthew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S31 - S33
  • [38] A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia
    Cavalcante M.S.
    Torres-Romero J.C.
    Lobo M.D.P.
    Moreno F.B.M.B.
    Bezerra L.P.
    Lima D.S.
    Matos J.C.
    Moreira R.A.
    Monteiro-Moreira A.C.O.
    Biomarker Research, 4 (1)
  • [39] Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia
    Wang, Yu
    Xue, Yu-juan
    Jia, Yue-ping
    Zuo, Ying-xi
    Lu, Ai-dong
    Zhang, Le-ping
    ACTA HAEMATOLOGICA, 2023, 146 (05) : 349 - 357
  • [40] Overexpression of CD49f in Precursor B-cell Acute Lymphoblastic Leukemia: Potential Usefulness in Minimal Residual Disease Detection
    DiGiuseppe, Joseph A.
    Fuller, Sheila G.
    Borowitz, Michael J.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (02) : 150 - 155
12345